Christopher Sayed, MD, discusses how hidradenitis suppurativa typically presents and looks forward, following the November approval of bimekizumab.
Christopher Sayed, MD
Advertisement
Christopher Sayed, MD, is dermatologist and professor at the University of North Carolina at Chapel Hill Department of Dermatology.
Articles by Christopher Sayed, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Prescription Access Crisis: 40% of GLP-1 RA Rx Are Unfilled
2
Value-Based Care Offers Solutions to Patient Access Challenges: Brian Mulherin, MD
3
New WHO Reports Sounds Alarm on Antimicrobial Resistance
4
Guideline-Directed Medical Therapies in Heart Failure
5
